Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Inhibiting DPP4 in a mouse model of HHT1 results in a shift towards regenerative macrophages and reduces fibrosis after myocardial infarction.

Dingenouts CKE, Bakker W, Lodder K, Wiesmeijer KC, Moerkamp AT, Maring JA, Arthur HM, Smits AM, Goumans MJ.

PLoS One. 2017 Dec 18;12(12):e0189805. doi: 10.1371/journal.pone.0189805. eCollection 2017.

2.

Thoracic Aortic Aneurysm Development in Patients with Bicuspid Aortic Valve: What Is the Role of Endothelial Cells?

van de Pol V, Kurakula K, DeRuiter MC, Goumans MJ.

Front Physiol. 2017 Nov 30;8:938. doi: 10.3389/fphys.2017.00938. eCollection 2017. Review.

3.

Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.

Kwon YC, Sasaki R, Meyer K, Ray R.

J Virol. 2017 Oct 13;91(21). pii: e01235-17. doi: 10.1128/JVI.01235-17. Print 2017 Nov 1.

PMID:
28794048
4.

The emerging role of alternative splicing in senescence and aging.

Deschênes M, Chabot B.

Aging Cell. 2017 Oct;16(5):918-933. doi: 10.1111/acel.12646. Epub 2017 Jul 13. Review.

5.

Endothelial follistatin-like-1 regulates the postnatal development of the pulmonary vasculature by modulating BMP/Smad signaling.

Tania NP, Maarsingh H, T Bos IS, Mattiotti A, Prakash S, Timens W, Gunst QD, Jimenez-Borreguero LJ, Schmidt M, van den Hoff MJB, Gosens R.

Pulm Circ. 2017 Mar 15;7(1):219-231. doi: 10.1177/2045893217702340. eCollection 2017 Mar.

6.

Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1.

Saito T, Bokhove M, Croci R, Zamora-Caballero S, Han L, Letarte M, de Sanctis D, Jovine L.

Cell Rep. 2017 May 30;19(9):1917-1928. doi: 10.1016/j.celrep.2017.05.011.

7.

Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling.

Jin Y, Muhl L, Burmakin M, Wang Y, Duchez AC, Betsholtz C, Arthur HM, Jakobsson L.

Nat Cell Biol. 2017 Jun;19(6):639-652. doi: 10.1038/ncb3534. Epub 2017 May 22.

8.

Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis.

Redgrave RE, Tual-Chalot S, Davison BJ, Singh E, Hall D, Amirrasouli MM, Gilchrist D, Medvinsky A, Arthur HM.

Stem Cell Reports. 2017 May 9;8(5):1287-1298. doi: 10.1016/j.stemcr.2017.04.015.

9.

Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading.

Tian H, Ketova T, Hardy D, Xu X, Gao X, Zijlstra A, Blobe GC.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1115-1126. doi: 10.1161/ATVBAHA.116.308859. Epub 2017 Apr 27. Erratum in: Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):e67.

10.

Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models.

Dourado KMC, Baik J, Oliveira VKP, Beltrame M, Yamamoto A, Theuer CP, Figueiredo CAV, Verneris MR, Perlingeiro RCR.

Blood. 2017 May 4;129(18):2526-2536. doi: 10.1182/blood-2017-01-763581. Epub 2017 Mar 28.

11.

Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.

Albiñana V, Zafra MP, Colau J, Zarrabeitia R, Recio-Poveda L, Olavarrieta L, Pérez-Pérez J, Botella LM.

BMC Med Genet. 2017 Feb 23;18(1):20. doi: 10.1186/s12881-017-0380-0.

12.

Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro.

Jarad M, Kuczynski EA, Morrison J, Viloria-Petit AM, Coomber BL.

BMC Cell Biol. 2017 Jan 23;18(1):10. doi: 10.1186/s12860-017-0127-y.

13.

PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia.

Ola R, Dubrac A, Han J, Zhang F, Fang JS, Larrivée B, Lee M, Urarte AA, Kraehling JR, Genet G, Hirschi KK, Sessa WC, Canals FV, Graupera M, Yan M, Young LH, Oh PS, Eichmann A.

Nat Commun. 2016 Nov 29;7:13650. doi: 10.1038/ncomms13650.

14.

Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility.

Rapp J, Kiss E, Meggyes M, Szabo-Meleg E, Feller D, Smuk G, Laszlo T, Sarosi V, Molnar TF, Kvell K, Pongracz JE.

BMC Cancer. 2016 Nov 23;16(1):915.

16.

Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery.

Farey JE, Fisher OM, Levert-Mignon AJ, Forner PM, Lord RV.

Obes Surg. 2017 Mar;27(3):578-585. doi: 10.1007/s11695-016-2321-y.

17.

Growth differentiation factor 6 derived from mesenchymal stem/stromal cells reduces age-related functional deterioration in multiple tissues.

Hisamatsu D, Ohno-Oishi M, Nakamura S, Mabuchi Y, Naka-Kaneda H.

Aging (Albany NY). 2016 Jun;8(6):1259-75. doi: 10.18632/aging.100982.

18.

Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression.

Brenet F, Scandura JM.

Mol Cell Oncol. 2015 Apr 18;2(3):e978703. doi: 10.4161/23723556.2014.978703. eCollection 2015 Jul-Sep. Review.

19.

Safety of targeting tumor endothelial cell antigens.

Wagner SC, Riordan NH, Ichim TE, Szymanski J, Ma H, Perez JA, Lopez J, Plata-Munoz JJ, Silva F, Patel AN, Kesari S.

J Transl Med. 2016 Apr 12;14:90. doi: 10.1186/s12967-016-0842-8. Review.

20.

Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response.

Ojeda-Fernández L, Recio-Poveda L, Aristorena M, Lastres P, Blanco FJ, Sanz-Rodríguez F, Gallardo-Vara E, de las Casas-Engel M, Corbí Á, Arthur HM, Bernabeu C, Botella LM.

PLoS Genet. 2016 Mar 24;12(3):e1005935. doi: 10.1371/journal.pgen.1005935. eCollection 2016 Mar.

Supplemental Content

Support Center